
Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.

Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.

An evidence-based analysis of 20 biotech startups poised for impact by 2026. Learn about key innovations in gene therapy, diagnostics, AI, and sustainability.

Explore the 2025 rare disease landscape, affecting 300 million people globally. Learn about diagnostic challenges, orphan drug development, and future policy di

An in-depth analysis of the specialty pharmacy industry covering key players (PBMs, distributors), market trends, biosimilar competition, PBM reform, and the economics of high-cost specialty drugs. Updated March 2026.

See the 2025 list of the most expensive drugs in the USA, led by multi-million dollar gene therapies like Lenmeldy & Elevidys for rare diseases. Learn why price
© 2026 IntuitionLabs. All rights reserved.